Allocations
Carey Olsen’s investment funds team in Jersey has advised Quinbrook Infrastructure Partners on the Jersey legal and regulatory aspects of Quinbrook Low Carbon Power Fund’s final closing, which raised a total of USD1.6 billion in primary and co-investment fund commitments.
Oak Group (Jersey) Limited (Oak) acted as Jersey administrator to the fund.
The fund focuses on investments in the ‘new build’ lower carbon and renewable energy sectors of the United States, the United Kingdom and Australia. The fund took advantage of the regulated ‘Jersey Eligible Investor Fund’ regime to target institutional investors, including those in the UK, US and
C5 Capital, a specialist venture capital firm focused on cyber security, data analytics and cloud computing, has anchored a USD17 million Series B financing round in Blue Cedar.
Daniel Freeman, Managing Partner at C5 Capital, will join Blue Cedar’s Board of Directors, bringing with him significant experience working with fast-growing cyber security software and services companies. Existing Blue Cedar investors, Benhamou Global Ventures (BGV), Generation Ventures, Grayhawk Capital and Sway Ventures, also participated.
Mobile security is increasingly a major concern for organisations, as data breaches can potentially cost them millions. While many of the world’s leading enterprises demonstrate increasing
This Private Equity Wire panel discussion, moderated by eFront, looked at PE allocation, portfolio construction, manager selection, fee negotiation, position monitoring and performance benchmarking, both from an LP and GP perspective…
PANELISTS:
David Arcauz: Managing Partner, Flexstone Partners
Cyril Demaria: Head of Private Markets, Wellershoff & Partners
Elias Korosis: Partner, Hermes GPE
Eric Malley, Founder and Chief Executive Officer, MG Capital
Moderator: Marija Djordjevic, Research Manager, eFront
Press the play button below to start the webinar
Last week was the biggest week for VCT fundraising this tax year with investors pouring GBP44.6m into VCTs. Over half of that (GBP24.5 million) was channeled into Octopus Titan, analysis from Wealth Club reveals.
The total for the tax year is now GBP527 million, just 9 per cent behind the GBP577 million raised in the same period in 2017/18.
Alex Davies, CEO and founder of Wealth Club, says: “Despite all the political uncertainty it’s looks like this is going to be another stellar year for VCTs, with investment so far just shy of the amount raised at the same point
Investment funds managed by TDR Capital, a UK based private equity investor, are to acquire 100 percent of NKD Group. TDR Capital and NKD’s current shareholder, OpCapita, have signed a sale & transfer agreement to that effect. The transaction is subject to the customary antitrust approval.
Established in 1962, NKD Group is among the leading ‘value retailers’ and local suppliers to the textiles retail trade in Central Europe. Textile discounter NKD offers a wide range of seasonal fashions, home textiles, and home accessories in its almost 1,800 stores. NKD employs some 8,000 people (6,350 of them in Germany) and generated
Standard Industrial Manufacturing Partners (Standard) has merged with DH Pump and Supply (DH Pump). A private equity fund managed by Hicks Equity Partners (HEP), the Dallas-based private equity arm of the Thomas O Hicks family office, initially invested in Standard alongside its former CEO, Jack Sitton, in July 2016.
Financial terms of this latest transaction have not ben disclosed.
Headquartered in Odessa, Texas with additional manufacturing in Granbury, Texas, Standard manufactures and distributes replacement parts for a wide range of pumps used in production and completion applications within the oil and gas industry. When a pump fails, Standard has
Belfast-based health tech company, Neurovalens, has secured one of the largest ever Series A investments generated by a Northern Irish technology company.
The company specialises in using neuroscience to solve everyday health issues.
The GBP4.6 million raise was led by London-based Wharton Asset Management along with Cambridge based IQ Capital. The round was also supported by Techstart Ventures, through its Invest NI-backed fund, The UU Fund, Co-Fund NI managed by Clarendon Fund Management, Beltrae Partners and the Angel CoFund.
Led by Dr Jason McKeown, Neurovalens is renowned for the development of Modius, an innovative headset which non-invasively stimulates the area
Hampleton Partners, an international mergers and acquisitions and corporate finance advisory firm for technology companies, has advised 2getthere Holding, a manufacturer of driverless electric shuttles, on its majority acquisition by ZF Friedrichshafen.
This is the second autonomous vehicle technology transaction closed by Hampleton within the space of nine months.
“Hampleton led a great process from start to finish, introducing us to an outstanding partner in ZF that will unlock the next dynamic growth phase of our company. Hampleton’s level of experience and, above all, profound understanding of the automotive market, led us to the best possible transaction,” says Carel van
Themis, an Africa-focussed power company backed by Denham Capital, is partnering with Kingline Development Nigeria Limited (Kingline) to develop a 550MW natural gas-fired power plant in Ondo State, Nigeria.
The Kingline Power Project is currently in its development stage with a target to proceed to financial close by Q2 2020, becoming fully operational in 2022. It will be located on 111 hectares of land in the Ondo State Industrial Park, adjacent to the existing Omotosho Power Plant.
At a Project cost of approximately USD600 million, the Project will be one of the lowest cost gas-to-power facilities in the international
OSF Ventures, the corporate investment arm of OSF HealthCare, is joining other health care systems and strategic investors from within the healthcare industry as a limited partner in Boston-based LRVHealth.
As part of LRVHealth’s collaborative innovation platform, which represents a network that delivers care to 50 million Americans across 25 states, OSF will help identify, create and invest in early-stage companies spanning healthcare IT, tech-enabled health services, medical devices, and diagnostics.
As a strategic investor in LRVHealth’s fourth fund, OSF HealthCare will benefit from access to early-stage companies that have been identified and vetted through a vast network that reaches
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
